• with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product...
    90 KB (8,728 words) - 08:35, 25 April 2024
  • 8437°E / 45.727; 4.8437 Sanofi Pasteur is the vaccines division of the French multinational pharmaceutical company Sanofi. Sanofi Pasteur is the largest...
    23 KB (2,049 words) - 16:12, 16 April 2024
  • Thumbnail for Hoechst AG
    Hoechst AG (category Sanofi)
    With the new company's 2004 merger with Sanofi-Synthélabo, it became a subsidiary of the resulting Sanofi-Aventis pharmaceuticals group. The company...
    7 KB (686 words) - 03:11, 10 March 2024
  • Thumbnail for Sanofi–GSK COVID-19 vaccine
    The Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. The Sanofi–GSK COVID‑19...
    18 KB (1,385 words) - 20:42, 22 January 2024
  • Amgen Inc. v. Sanofi, 598 U.S. 594 (2023), is a United States Supreme Court case in which the Court held that Amgen's two patent applications on cholesterol-lower...
    10 KB (921 words) - 05:37, 26 February 2024
  • Thumbnail for Genzyme
    Genzyme (category Sanofi)
    innovators. In February 2022, Sanofi's new corporate brand was unveiled and former entity "Sanofi Genzyme" got integrated into Sanofi. The company was started...
    22 KB (2,013 words) - 05:32, 8 May 2024
  • Thumbnail for Valproate
    Depakin (Sanofi S.R.L. Italy) Depakine (Sanofi Aventis France) Depakine (Sanofi Synthelabo Romania) Depalept (Sanofi Aventis Israel) Deprakine (Sanofi Aventis...
    92 KB (7,947 words) - 19:43, 21 April 2024
  • Thumbnail for Dupilumab
    Dupilumab (category Sanofi)
    cell called eosinophils. It was developed by Regeneron Pharmaceuticals and Sanofi Genzyme. It received approval from the US Food and Drug Administration (FDA)...
    22 KB (1,841 words) - 22:50, 30 April 2024
  • Thumbnail for Sanofi–Translate Bio COVID-19 vaccine
    The Sanofi–Translate Bio COVID-19 vaccine, also known as MRT5500 or VAW00001, was a COVID-19 vaccine candidate developed by Sanofi Pasteur and Translate...
    5 KB (284 words) - 12:28, 25 August 2023
  • – Sankyo Pharma UK Ltd Sanofi-Aventis – Sanofi-Aventis Ltd Sanofi Oasteur – Sanofi Pasteur MSD Ltd Sanofi-Synthélabo – Sanofi-Aventis Ltd Schering-Plough...
    8 KB (815 words) - 09:15, 2 April 2024